DAVIGNON ETIENNE 4
4 · GILEAD SCIENCES INC · Filed May 14, 2013
Insider Transaction Report
Form 4
DAVIGNON ETIENNE
Director
Transactions
- Exercise/Conversion
Common Stock
2013-05-10+5,852→ 1,171,720 total - Exercise/Conversion
Restricted Stock Units
2013-05-10−5,852→ 2,863 total→ Common Stock (5,852 underlying) - Tax Payment
Common Stock
2013-05-10$52.88/sh−1,756$92,857→ 1,169,964 total
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]100% of the restricted stock units vested on May 10, 2013, at the end of the first year of service.